Skip to content
10-K

Annual Report

AEOLUS PHARMACEUTICALS, INC.

0001199073-16-000300

← back to feed
Filed
Dec 20, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Dec 16, 2016 152.09M sh
Shares Diluted FY 2016 · Sep 30, 2016 148.67K sh
Shares Diluted FY 2016 · Sep 30, 2015 135.88K sh
Operating Cash Flow FY 2016 · Sep 30, 2016 −$3.11M
Operating Cash Flow FY 2016 · Sep 30, 2015 −$2.44M
Cash And Equivalents FY 2016 · Sep 30, 2016 $3.16M
Cash And Equivalents FY 2016 · Sep 30, 2015 $94K
Cash And Equivalents FY 2016 · Sep 30, 2014 $1.52M
Stockholders Equity FY 2016 · Sep 30, 2016 $3.2M
Stockholders Equity FY 2016 · Sep 30, 2015 −$845K
Stockholders Equity FY 2016 · Sep 30, 2014 $1.59M
Current Liabilities FY 2016 · Sep 30, 2016 $972K
Current Liabilities FY 2016 · Sep 30, 2015 $2.62M
Total Liabilities FY 2016 · Sep 30, 2016 $972K
Total Liabilities FY 2016 · Sep 30, 2015 $2.62M
Current Assets FY 2016 · Sep 30, 2016 $4.14M
Current Assets FY 2016 · Sep 30, 2015 $1.75M
Total Assets FY 2016 · Sep 30, 2016 $4.17M
Total Assets FY 2016 · Sep 30, 2015 $1.78M
Eps Diluted FY 2016 · Sep 30, 2016 −$0.04
Eps Diluted FY 2016 · Sep 30, 2015 −$0.02
Eps Basic FY 2016 · Sep 30, 2016 −$0.04
Eps Basic FY 2016 · Sep 30, 2015 −$0.02
Sga Expense FY 2016 · Sep 30, 2016 $2.47M
Sga Expense FY 2016 · Sep 30, 2015 $2.23M
Rd Expense FY 2016 · Sep 30, 2016 $2.88M
Rd Expense FY 2016 · Sep 30, 2015 $3.51M
Net Income FY 2016 · Sep 30, 2016 −$3.56M
Net Income FY 2016 · Sep 30, 2015 −$2.63M
Operating Income FY 2016 · Sep 30, 2016 −$3.27M
Operating Income FY 2016 · Sep 30, 2015 −$2.63M